Articles

• All
• CVD
• CKD
• Dialysis
• SGLT2i
• Hypertension
• Hyperglycaemia
• AKI
• RAAS
• Anaemia
• Transplantation

• 

  Dapagliflozin and cardiovascular risks with worsening renal function

  7 Oct 2023

  • CKD
  • CVD
  • SGLT2i

• 

  Cardiorenal biomarkers in the CREDENCE trial

  6 Oct 2023

  • CKD
  • CVD
  • SGLT2i

• 

  Longitudinal B-type natriuretic peptide monitoring and kidney failure

  22 Jul 2023

  • CKD
  • CVD
  • AKI

• 

  Chronic kidney disease: cost-effectiveness of screening

  26 Jun 2023

  • CVD

• 

  Cardioprotective effect of acute intradialytic exercise: a comprehensive speckle-tracking echocardiography analysis

  11 Jun 2023

  • CVD
  • Dialysis
  • Editorial

• 

  The impact of acute intradialytic exercise on cardioprotection

  10 Jun 2023

  • Dialysis
  • CVD

• 

  Sodium–glucose cotransporter 2 inhibitors in heart failure: does it matter how they work?

  16 May 2023

  • SGLT2i
  • CVD
  • Editorial

• 

  EMPA-VISION: Cardiac energy in people with heart failure taking empagliflozin

  15 May 2023

  • SGLT2i
  • CVD

• 

  Chronic kidney disease and incident heart failure: insights from the Atherosclerosis Risk in Communities study

  14 May 2023

  • CKD
  • CVD